GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
1.100
-0.010 (-0.90%)
At close: Apr 28, 2026, 4:00 PM EDT
1.110
+0.010 (0.91%)
After-hours: Apr 28, 2026, 5:21 PM EDT
GeoVax Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 2.49 | 3.95 | - | 0.08 | 0.39 | |
| Revenue Growth (YoY) | -37.06% | - | - | -78.85% | -78.86% | |
| Cost of Revenue | 18.12 | 23.71 | 20.72 | 9.12 | 15.55 | |
| Gross Profit | -15.63 | -19.76 | -20.72 | -9.04 | -15.17 | |
| Selling, General & Admin | 6.01 | 5.39 | 6.02 | 4.99 | 3.58 | |
| Operating Expenses | 6.01 | 5.39 | 6.02 | 4.99 | 3.58 | |
| Operating Income | -21.64 | -25.14 | -26.74 | -14.03 | -18.75 | |
| Interest Expense | - | -0.02 | - | - | -0 | |
| Interest & Investment Income | 0.17 | 0.17 | 0.78 | 0.01 | 0 | |
| EBT Excluding Unusual Items | -21.46 | -24.99 | -25.97 | -14.02 | -18.74 | |
| Other Unusual Items | - | - | - | - | 0.17 | |
| Pretax Income | -21.46 | -24.99 | -25.97 | -14.02 | -18.57 | |
| Net Income | -21.46 | -24.99 | -25.97 | -14.02 | -18.57 | |
| Net Income to Common | -21.46 | -24.99 | -25.97 | -14.02 | -18.57 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 361.94% | 185.43% | 60.60% | 178.26% | - | |
| EPS (Basic) | -22.40 | -120.46 | -357.22 | -309.78 | -1141.66 | |
| EPS (Diluted) | -22.40 | -120.46 | -357.22 | -309.78 | -1141.66 | |
| Free Cash Flow | -21.5 | -24.7 | -25.22 | -19.16 | -11.24 | |
| Free Cash Flow Per Share | -22.43 | -119.03 | -346.98 | -423.41 | -691.27 | |
| Operating Margin | -869.34% | -635.83% | - | -17207.47% | -4862.72% | |
| Profit Margin | -862.34% | -631.98% | - | -17198.35% | -4817.19% | |
| Free Cash Flow Margin | -863.81% | -624.50% | - | -23507.18% | -2916.76% | |
| EBITDA | -21.57 | -25.05 | -26.67 | -13.97 | -18.71 | |
| D&A For EBITDA | 0.07 | 0.1 | 0.07 | 0.06 | 0.04 | |
| EBIT | -21.64 | -25.14 | -26.74 | -14.03 | -18.75 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.